Related Experiment Videos
[Does screening influence mortality of colorectal cancer?]
1Kirurgiska kliniken, Sahlgrenska sjukhuset, Göteborg.
Lakartidningen
|February 20, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
CEA, CA 50 and CA 242 in patients surviving colorectal cancer without recurrent disease.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2001
Screening for colorectal cancer using the faecal occult blood test, hemoccult.
The Cochrane database of systematic reviews·2000
Standard serum concentrations and normal fluctuations of CEA, CA 50 and CA 242 during twelve months in men and women aged 60-64 years without malignant disease.
The European journal of surgery = Acta chirurgica·1999
A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult.
BMJ (Clinical research ed.)·1998
Worry associated with screening for colorectal carcinomas.
Scandinavian journal of gastroenterology·1997
[Postoperative atrial fibrillation after open heart surgery].
Lakartidningen·2026
[Interaction between psychotic patients and AI-driven chatbots].
Lakartidningen·2026
[Superficial venous thrombosis of the lower extremities].
Lakartidningen·2026
[Switch from STEMI to OMI].
Lakartidningen·2026
[Maxillomandibular advancement].
Lakartidningen·2026
A Multimodal Graph Neural Network Based on MRI Radi-omics for Prognostic Prediction in Locally Advanced Cervical Squamous Cell Carcinoma.
Cancer control : journal of the Moffitt Cancer Center·2026
Outcomes That Matter in Gastrointestinal Cancer Care: A Focus Group Study of Patient-Centred Outcomes Identified by Patients and Care Partners.
Health expectations : an international journal of public participation in health care and health policy·2026
Nicotinamide Metabolism Constrains Memory CD8+ T Cell Formation Through a Putative HS1BP3-SIRT1-FOXO3-BCL6 Axis.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
GLP-1 receptor agonist therapy is associated with increased symptomatic remission in ulcerative colitis: a matched cohort study.
Inflammatory bowel diseases·2026
Modulating immune toxicity in ulcerative colitis using a small molecule RAB27A inhibitor.
Inflammatory bowel diseases·2026